golimumab
janssen
[' psa', 'golimumab', 'axspa']
#abst0129 #acr22 analysis 6 euro studies of active ra, psa, axspa &amp;secondary failure of tnf i showed golimumab to be effective 2nd-line rx. glm show improvement in dis activity, qol&amp; high retention( 2/3 pts on rx after 12mo). 
Rheumatologist at Scarsdale Medical Group, Runner, Traveler Opinions are my own